Investor Presentaiton

Our Future Growth Strategy... Strategy Expansion Expansion of current product portfolio in regulated market Product Launch New product development and launch Growth Levers The company generates ~95% of its revenue from regulated markets and expects to further expand in these markets through continued push of existing products and new launches in regulated and other related geographies Will continue to add new 4-6 new products in UK, USA every year which are expected to drive revenue growth to Rs 2,000 crores and beyond in the next few years Inorganic Expansion Inorganic expansion to enhance manufacturing capabilities, product portfolio, newer markets The company has plans to acquire manufacturing assets in India as well as marketing licenses in Europe and USA and emerging markets to expand business operations in global markets Backward Integration Backward integration into API manufacturing Plans to backward integrate into API manufacturing (for captive consumption thereby having presence in the entire value chain) ©2021 - Marksans Pharma Limited, All Rights Reserved. 31

View entire presentation